{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:19:28Z","timestamp":1788970768200,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.vascn.2026.108568","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:19:18Z","timestamp":1785338358000},"page":"108568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Advancing safety pharmacology: Emerging technologies, innovative methods, and future directions"],"prefix":"10.1016","volume":"141","author":[{"given":"Michael K.","family":"Pugsley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett R.","family":"Winters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutfiya","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Authier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vascn.2026.108568_bb0005","series-title":"The pharmacology of functional, biochemical, and recombinant receptor systems","first-page":"15","article-title":"Human vascular receptors in disease: Pharmacodynamic analyses in isolated tissue","author":"Angus","year":"2000"},{"key":"10.1016\/j.vascn.2026.108568_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-662-46943-9_1","article-title":"A historical view and vision into the future of the field of safety pharmacology","volume":"229","author":"Bass","year":"2015","journal-title":"Handbook of Experimental Pharmacology"},{"issue":"3","key":"10.1016\/j.vascn.2026.108568_bb0015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.vascn.2004.02.004","article-title":"Introduction to nonclinical safety pharmacology and the safety pharmacology society","volume":"49","author":"Bass","year":"2004","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2026.108568_bb0020","doi-asserted-by":"crossref","first-page":"108566","DOI":"10.1016\/j.vascn.2026.108566","article-title":"Detecting drug-induced EEG alterations with machine learning: A methodological proof-of-concept study in rats treated with MK-801","volume":"140","author":"Basset","year":"2026","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2026.108568_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2026.108430","article-title":"Non-invasive, home cage digital monitoring for improved safety pharmacology assessments in drug development: ICH S7A update considerations","volume":"140","author":"Berridge","year":"2026","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2026.108568_bb0030","doi-asserted-by":"crossref","first-page":"108563","DOI":"10.1016\/j.vascn.2026.108563","article-title":"From surplus to scientific value: Repurposing vascular tissues for organ bath standardization to de-risk vasoactive liabilities","volume":"140","author":"Coonen","year":"2026","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2026.108568_bb0035","doi-asserted-by":"crossref","DOI":"10.1007\/s00204-026-04414-y","article-title":"Transforming animal study toxicology reports into structured, harmonized data using large language models","author":"Doktorova","year":"2026","journal-title":"Archives of Toxicology"},{"key":"10.1016\/j.vascn.2026.108568_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2026.1758963","article-title":"Appearance-based computer vision pipeline for multi-animal monitoring of canine activity, behavior and clinical observations","volume":"8","author":"Eberhardt","year":"2026","journal-title":"Frontiers in Toxicology"},{"key":"10.1016\/j.vascn.2026.108568_bb0045","doi-asserted-by":"crossref","first-page":"108564","DOI":"10.1016\/j.vascn.2026.108564","article-title":"Predicting thorough QT safety profile using hERG IC10 versus IC50","volume":"140","author":"Edwards","year":"2026","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2026.108568_bb0050","author":"FDA"},{"key":"10.1016\/j.vascn.2026.108568_bb0055","author":"FDA"},{"issue":"6","key":"10.1016\/j.vascn.2026.108568_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.270","article-title":"Application of a systems pharmacology model for translational prediction of hERG-mediated QTc prolongation","volume":"4","author":"Gotta","year":"2016","journal-title":"Pharmacology Research & Perspectives"},{"key":"10.1016\/j.vascn.2026.108568_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2020.106889","article-title":"INSPIRE: A European training network to foster research and training in cardiovascular safety pharmacology","volume":"105","author":"Guns","year":"2020","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2026.108568_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2026.108433","article-title":"The INSPIRE doctoral network in safety pharmacology - looking back and ahead","volume":"140","author":"Guns","year":"2026","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2026.108568_bb0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.vascn.2017.04.002","article-title":"Cardiac voltage-gated ion channels in safety pharmacology: Review of the landscape leading to the CiPA initiative","volume":"87","author":"Huang","year":"2017","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2026.108568_bb0080","series-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use","article-title":"S7A safety pharmacology studies for human pharmaceuticals","author":"ICH","year":"2001"},{"key":"10.1016\/j.vascn.2026.108568_bb0085","series-title":"E14 Clinical Evaluation of QT\/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs","author":"ICH","year":"2005"},{"key":"10.1016\/j.vascn.2026.108568_bb0090","series-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use","article-title":"S7B nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals","author":"ICH","year":"2005"},{"key":"10.1016\/j.vascn.2026.108568_bb0095","series-title":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use","article-title":"E14\/S7B Implementation Working Group: Clinical and Nonclinical Evaluation of QT\/QTc Interval Prolongation an Proarrhythmic Potantial Questions and Answers","author":"ICH","year":"2022"},{"key":"10.1016\/j.vascn.2026.108568_bb0100","series-title":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use","article-title":"ICH E14\/S7B implementation working group: E14\/S7B questions and answers: Clinical and nonclinical evaluation of QT\/QTc interval prolongation and proarrhythmic potential. Training Materials","author":"ICH","year":"2022"},{"issue":"12","key":"10.1016\/j.vascn.2026.108568_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105625","article-title":"Machine learning-based clustering and classification of mouse behaviors via respiratory patterns","volume":"25","author":"Janke","year":"2022","journal-title":"iScience"},{"issue":"6","key":"10.1016\/j.vascn.2026.108568_bb0110","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.clpt.2005.02.004","article-title":"A pharmacokinetic-pharmacodynamic model for the quantitative prediction of dofetilide clinical QT prolongation from human ether-a-go-go-related gene current inhibition data","volume":"77","author":"Jonker","year":"2005","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"3","key":"10.1016\/j.vascn.2026.108568_bb0115","doi-asserted-by":"crossref","DOI":"10.1093\/ehjdh\/ztag031","article-title":"Artificial intelligence-based automated interpretation of images of electrocardiograms: Development and multinational validation of ECG-GPT","volume":"7","author":"Khunte","year":"2026","journal-title":"European Heart Journal, Digital Health"},{"issue":"3","key":"10.1016\/j.vascn.2026.108568_bb0120","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00204-023-03666-2","article-title":"Artificial intelligence (AI)-it's the end of the tox as we know it (and I feel fine)","volume":"98","author":"Kleinstreuer","year":"2024","journal-title":"Archives of Toxicology"},{"key":"10.1016\/j.vascn.2026.108568_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2026.108424","article-title":"The emerging use of artificial intelligence in safety pharmacology and toxicology","volume":"139","author":"Miller","year":"2026","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"7","key":"10.1016\/j.vascn.2026.108568_bb0130","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/bjp.2008.280","article-title":"Principles of safety pharmacology","volume":"154","author":"Pugsley","year":"2008","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2026.108568_bb0135","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.vascn.2018.01.001","article-title":"An overview of the safety pharmacology society strategic plan","volume":"93","author":"Pugsley","year":"2018","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"2","key":"10.1016\/j.vascn.2026.108568_bb0140","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S1056-8719(00)00125-8","article-title":"The vascular system. An overview of structure and function","volume":"44","author":"Pugsley","year":"2000","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2026.108568_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2023.107270","article-title":"Best practice considerations for nonclinical in vivo cardiovascular telemetry studies in non-rodent species: Delivering high quality QTc data to support ICH E14\/S7B Q&as","volume":"123","author":"Rossman","year":"2023","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2026.108568_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2025.107763","article-title":"Results from an EFPIA, JPMA, PhRMA industry survey on reopening and revamping the ICH S7A guidance on safety and secondary pharmacology","volume":"135","author":"Valentin","year":"2025","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2026.108568_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2023.105368","article-title":"2000-2023 over two decades of ICH S7A: Has the time come for a revamp?","volume":"139","author":"Valentin","year":"2023","journal-title":"Regulatory Toxicology and Pharmacology"},{"key":"10.1016\/j.vascn.2026.108568_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2025.105795","article-title":"Points to consider for revising the ICH S7A guideline on safety and secondary pharmacology","volume":"159","author":"Valentin","year":"2025","journal-title":"Regulatory Toxicology and Pharmacology"},{"issue":"1","key":"10.1016\/j.vascn.2026.108568_bb0165","first-page":"116","article-title":"Towards a drug concentration effect relationship for QT prolongation and torsades de pointes","volume":"5","author":"Webster","year":"2002","journal-title":"Current Opinion in Drug Discovery & Development"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871926001619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871926001619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:58:55Z","timestamp":1788969535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871926001619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":33,"alternative-id":["S1056871926001619"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2026.108568","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancing safety pharmacology: Emerging technologies, innovative methods, and future directions","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2026.108568","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108568"}}